Clinical Chemistry Podcast · Association for Diagnostics and Laboratory Medicine
Diagnostic Value of Digital Estimates of Trophoblastic Mosaicism in Genome-Wide Cell-Free Fetal DNA Screening
·19 min·1 clip
Dr. Martens discovered that if less than 50% of placental cells show an anomaly, the fetus has zero risk—a game-changer for prenatal screening.
As heard by us
A practical look at how trophoblastic mosaicism can help separate placental-only findings from cases more likely to matter for the fetus.
This discussion tracks a practical prenatal screening problem: how cell-free fetal DNA testing can pick up rare chromosomal findings while avoiding unnecessary invasive follow-up.
Why you'd press play
You want a clear read on when rare prenatal screen results really deserve amniocentesis.
Listen to the show on